<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink">
  <front>
    <journal-meta />
    <article-meta>
      <title-group>
        <article-title>Adverse events following immunization: reporting standardization, automatic case classification and signal detection</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <string-name>M e´lanie Courtot</string-name>
          <xref ref-type="aff" rid="aff0">0</xref>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Ryan R. Brinkman</string-name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <string-name>Alan Ruttenberg</string-name>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <aff id="aff0">
          <label>0</label>
          <institution>BC Cancer Agency</institution>
          ,
          <addr-line>Vancouver, BC</addr-line>
          ,
          <country country="CA">Canada</country>
        </aff>
        <aff id="aff1">
          <label>1</label>
          <institution>Department of Medical Genetics, University of British Columbia</institution>
          ,
          <addr-line>Vancouver, BC</addr-line>
          ,
          <country country="CA">Canada</country>
        </aff>
        <aff id="aff2">
          <label>2</label>
          <institution>School of Dental Medicine, University at Buffalo</institution>
          ,
          <addr-line>NY</addr-line>
          ,
          <country country="US">USA</country>
        </aff>
      </contrib-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec-1">
      <title>BACKGROUND</title>
      <p>Analysis of spontaneous reports of Adverse Events Following
Immunization (AEFIs) is an important way to identify potential
problems in vaccine safety and efficacy and summarize experience
for dissemination to health care authorities. However, current
reporting methods are not sufficiently controlled. While there is
general adoption of Medical Dictionary of Regulatory Activities
(MedDRA) in the reporting systems we consider, definitions are
not provided for MedDRA terms, reports are not annotated in
a consistent manner, differing in experience of annotator, and
annotation is done either at entry time, or post-hoc. Sometimes, only
the final adverse event code is saved, discarding evidence supporting
the diagnosis. Because of these practices, interpretation of such
spontaneous reports is tedious, costly and time consuming. The
Adverse Event Reporting Ontology (AERO) we are building plays
a role in increasing accuracy and quality of reporting, ultimately
enhancing response time to adverse event signals.</p>
    </sec>
    <sec id="sec-2">
      <title>METHODS</title>
      <p>In order to address these deficiencies, we work with the Brighton
Collaboration who has done extensive work towards standardization
of case definitions and diagnostic criteria for vaccine adverse events.
Based on our initial results with AERO, a working group has been
established within the Brighton network, including representation
from the Public Health Agency of Canada (PHAC) and the
US Food and Drug Administration (FDA), to incorporate logical
representations of Brighton case definitions into AERO, with the
aim of increasing quality and accuracy of AEFI reporting. As an
example, only 9% of the Vaccine Adverse Event Reporting System
(VAERS) anaphylaxis reports post-H1N1vaccination early 2010
were correctly annotated with the MedDRA anaphylaxis term.</p>
      <p>Working within the framework being established by the Open
Biological and Biomedical Ontologies (OBO) Foundry, the Adverse
Events Reporting Ontology (AERO) first documents assessments
of relevant signs and symptoms textually. These elements of
AEFI reports are then logically defined by being positioned into a
hierarchy and related to each other in a way that supports computing
an overall diagnosis. Our system allows automatic inference of a
diagnosis according to the Brighton criteria based on the evidence
encoded in the MedDRA annotations.
3</p>
    </sec>
    <sec id="sec-3">
      <title>RESULTS</title>
      <p>Our approach allows us to unambiguously refer to a specific set of
carefully defined signs and symptoms at the time of data entry, as
well as an overall diagnosis that remains linked to its associated
signs and symptoms. The adverse event diagnosis is formally
expressed, making it amenable to further querying for example
for statistical analysis (“what percentage of patients presented
with motor manifestations?”) and at different levels of granularity.
Finally, by enabling automatic processing of adverse events reports,
we will decrease time and money needed for their evaluation. This
may allow earlier detection of adverse events signal in the datasets,
and trigger a warning for experts to further investigate.</p>
    </sec>
  </body>
  <back>
    <ref-list />
  </back>
</article>